Author:
Liao Shouzhu,Chen Hongjun,Wang Guifei,Wu Shuming,Yang Zaiyou,Luo Weihe,Liu Zhuanfeng,Gao Xun,Qin Junhai,Li Chuan-hua,Wang Zhongqing
Funder
State Key Laboratory of Anti-Infective Drug Development
Key research and development program of Guangdong Province, China
Hunan Provincial Natural Science Foundation
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Reference23 articles.
1. A review in partial-onset (focal) seizures in patients with epilepsy;Hoy;CNS Drugs,2016
2. Brivaracetam: first global approval;Markham;Drugs,2016
3. 4-Substituted pyrrolidin-2-ones and their use;Ates;PCT Int. Patent Appl. WO 2007/031263 A1,2007
4. 2-Oxo-1-Pyrrolidine derivatives, processes for preparing them and their uses;Differding;PCT Int. Patent Appl. WO2001/062726A2,2001
5. Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity;Kenda;J. Med. Chem.,2004
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献